Highlights of the results
- Consolidated net profit: 1.92 billion rupees, up more than 27 per cent.
- Consolidated revenue from operations: 8.74 billion rupees, up nearly 20 per cent.
- Samples tested: up 13.6 per cent.
- Network: 312 labs as of March 31.
- Share price: up 3.6 per cent.
Growing health awareness
According to management, the diagnostics industry is benefiting from rising health awareness among Indians and expanding access to services.
The diagnostics industry continues to benefit from increasing healthcare awareness, rising adoption of preventive health check-ups, and expanding access to diagnostic services across India.
– Ved Goel, Group CFO and CEO, international business, Dr Lal PathLabs

















